| [1] |
Vayrynen J, Bohm J. Inflammation and cancer-colorectal carcinoma as an example [J]. Duodecim, 2016, 132(2): 137-144.
|
| [2] |
Libby P, Kobold S. Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology [J]. Cardiovasc Res, 2019, 115(5): 824-829.
|
| [3] |
Padoan A, Plebani M, Basso D. Inflammation and pancreatic cancer: focus on metabolism, cytokines, and immunity [J]. Int J Mol Sci, 2019, 20(3): 676.
|
| [4] |
Amin MN, Hussain MS, Sarwar MS, et al. How the association between obesity and inflammation may lead to insulin resistance and cancer [J]. Diabetes Metab Syndr, 2019, 13(2): 1213-1224.
|
| [5] |
Schwiebs A, Herrero San Juan M, Schmidt KG, et al. Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase [J]. Oncogene, 2019, 38(24): 4788-4803.
|
| [6] |
Kostic AD, Chun E, Meyerson M, et al. Microbes and inflammation in colorectal cancer [J]. Cancer Immunol Res, 2013, 1(3): 150-157.
|
| [7] |
Wang D, Dubois RN. The role of COX-2 in intestinal inflammation and colorectal cancer [J]. Oncogene, 2010, 29(6): 781-788.
|
| [8] |
Lee IK, Vansaun MN, Shim JH, et al. Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer [J]. J Surg Res, 2013, 180(2): 252-259.
|
| [9] |
Toriola AT, Cheng TY, Neuhouser ML, et al. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers [J]. Int J Cancer, 2013, 132(11): 2648-2658.
|
| [10] |
Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation [J]. Am J Physiol Gastrointest Liver Physiol, 2004, 287(1): G7-17.
|
| [11] |
Bergman M, Djaldetti M, Salman H, et al. Inflammation and colorectal cancer: does aspirin affect the interaction between cancer and immune cells? [J]. Inflammation, 2011, 34(1): 22-28.
|
| [12] |
Dirnhofer S, Zippelius A. Cancer immunology, inflammation, and tolerance: an introduction [J]. Virchows Arch, 2019, 474(4): 405-406.
|
| [13] |
Lin HL, Lin HC, Lin CC, et al. Increased risk of colorectal cancer among patients with biliary tract inflammation: a 5-year follow-up study [J]. Int J Cancer, 2011, 128(2): 447-452.
|
| [14] |
Kraus S, Arber N. Inflammation and colorectal cancer [J]. Curr Opin Pharmacol, 2009, 9(4): 405-410.
|
| [15] |
Slattery ML, Mullany LE, Sakoda L, et al. The NF-kappaB signalling pathway in colorectal cancer: associations between dysregulated gene and miRNA expression [J]. J Cancer Res Clin Oncol, 2018, 144(2): 269-283.
|
| [16] |
Xiao YC, Yang ZB, Cheng XS, et al. CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis [J]. Cancer Lett, 2015, 361(1): 22-32.
|
| [17] |
Chung P, Cook T, Liu K, et al. Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism [J]. Nitric Oxide, 2003, 8(2): 119-126.
|
| [18] |
Jekarl DW, Kim JY, Ha JH, et al. Diagnosis and prognosis of sepsis based on use of cytokines, chemokines, and growth factors [J]. Dis Markers, 2019, 2019: 1089107.
|
| [19] |
Wang N, Wang L, Yang H, et al. Multiple genetic variants are associated with colorectal cancer risk in the Han Chinese population [J]. Eur J Cancer Prev, 2015, 24(1): 1-5.
|
| [20] |
Gelfo V, Rodia MT, Pucci M, et al. A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors [J]. Oncotarget, 2016, 7(44): 72167-72183.
|
| [21] |
Johnstone M, Bennett N, Standifer C, et al. Characterization of the pro-Inflammatory cytokine IL-1beta on butyrate oxidation in colorectal cancer cells[J]. J Cell Biochem, 2017, 118(6): 1614-1621.
|
| [22] |
Kopp TI, Vogel U, Tjonneland A, et al. Meat and fiber intake and interaction with pattern recognition receptors (TLR1, TLR2, TLR4, and TLR10) in relation to colorectal cancer in a Danish prospective, case-cohort study [J]. Am J Clin Nutr, 2018, 107(3): 465-479.
|
| [23] |
Andersen V, Holst R, Kopp TI, et al. Interactions between diet, lifestyle and IL10, IL1B, and PTGS2/COX-2 gene polymorphisms in relation to risk of colorectal cancer in a prospective Danish case-cohort study [J]. PLoS One, 2013, 8(10): e78366.
|
| [24] |
Cheng XS, Li YF, Tan J, et al. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition [J]. Cancer Lett, 2014, 348(1-2): 77-87.
|
| [25] |
Rial NS, Lazennec G, Prasad AR, et al. Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancer [J]. Int J Cancer, 2009, 124(10): 2270-2280.
|
| [26] |
Schirripa M, Zhang W, Yang D, et al. NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients [J]. PLoS One, 2018, 13(3): e0193640.
|
| [27] |
Shin EJ, Sung MJ, Park JH, et al. Poly-gamma-glutamic acid induces apoptosis via reduction of COX-2 expression in TPA-induced HT-29 human colorectal cancer cells [J]. Int J Mol Sci, 2015, 16(4): 7577-7586.
|
| [28] |
Hong SK, Gul YA, Ithnin H, et al. Expression of beta-catenin, COX-2 and iNOS in colorectal cancer: relevance of COX-2 adn iNOS inhibitors for treatment in Malaysia [J]. Asian J Surg, 2004, 27(1): 10-17.
|
| [29] |
Li X, Zhong Q, Luo D, et al. The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer [J]. PLoS One, 2019, 14(4): e0214611.
|